Compounds > naproxen
Page last updated: 2024-09-04

naproxen and pirenzepine

naproxen has been researched along with pirenzepine in 6 studies

Compound Research Comparison

Studies
(naproxen)		Trials
(naproxen)		Recent Studies (post-2010)
(naproxen)		Studies
(pirenzepine)		Trials
(pirenzepine)		Recent Studies (post-2010) (pirenzepine)
4,5511,0571,4293,812587140

Protein Interaction Comparison

ProteinTaxonomynaproxen (IC50)pirenzepine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.6891
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.5856
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)0.6134
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)0.6222
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)0.6227
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.6227
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.3406
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)0.6281
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0291
Muscarinic acetylcholine receptor M1Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.9556
Muscarinic acetylcholine receptor M4Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M5Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M3Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M2Mus musculus (house mouse)0.51

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S1
Akamatsu, M1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1

Other Studies

6 other study(ies) available for naproxen and pirenzepine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Bioorganic & medicinal chemistry, 2007, Jun-01, Volume: 15, Issue:11

    Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship

2007
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
    Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19

    Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship

2009
Importance of physicochemical properties for the design of new pesticides.
    Journal of agricultural and food chemistry, 2011, Apr-13, Volume: 59, Issue:7

    Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012